Overview: The U.S. Pharmacopeial Convention (USP), through the USAID-funded Promoting the Quality of Medicines Plus (PQM+) program, is collaborating with the Directorate General of Drug Administration (DGDA) to enhance regulatory efficiency and pharmaceutical governance in Bangladesh. This project is focused on achieving WHO maturity level-3 for DGDA and WHO-prequalification for the National Drug Control Laboratory (NDCL), ensuring that Bangladesh strengthens its regulatory framework for quality medicines.
Objectives: The objectives of the project are to collaborate with the Directorate General of Drug Administration (DGDA) and relevant stakeholders to define clear development goals, and to develop a digital architectural blueprint that will guide the transformation process. A comprehensive digitization roadmap will be created to align with DGDA’s strategic vision, ensuring a cohesive approach to digital initiatives. Additionally, an in-depth assessment of the current IT infrastructure will be conducted to identify areas for improvement, and expert recommendations will be provided for the implementation of electronic systems within the regulatory framework. The project will also focus on integrating cross-functional digital solutions to streamline operations and enhance efficiency in regulatory processes.
Contribution: PQM+ and IntraHealth will assist DGDA in developing a revised IT departmental structure to support the implementation and sustainability of digital initiatives. This initiative will align with DGDA’s five-year strategic plan, improving transparency, data integrity, and overall efficiency of regulatory functions. Ultimately, this project will contribute to the availability of safe, high-quality medicines in Bangladesh, fostering public health and regulatory excellence.
Execution: JBRSOFT is working closely with DGDA to develop the digital architectural blueprint and comprehensive roadmap for the project. This involves conducting a thorough assessment of the current IT infrastructure, identifying existing gaps, and providing expert recommendations for the implementation of electronic systems. Additionally, JBRSOFT is facilitating the integration of cross-functional digital solutions to ensure data integrity and regulatory efficiency. Through these efforts, JBRSOFT aims to support the alignment of DGDA's systems with the National Digital Health Strategy, enabling sustainable digital transformation and enhancing the regulatory framework for the long-term benefit of Bangladesh’s pharmaceutical sector.